Practice Guideline for the Treatment of Patients with Attention-Deficit/Hyperactivity Disorder. These guidelines offer insights into the best practices for the treatment of ADHD, including the use of stimulant medications like Adderall
None of this is glamorous
This reduction likely results from glucagon-mediated enhancement of hepatic LDL receptor expression and increased cholesterol catabolism through bile acid synthesis
Duloxetine DR may also cause side effects including but not limited to nausea, dry mouth, drowsiness, headache, fatigue, weight loss
Some people lose weight with mild side effects, while others may have stronger symptoms
After undergoing extensive preclinical optimization and multiple successful clinical phases globally and in China, mazdutide received marketing approval in China in June 2025 under the brand name Xinermei, becoming the first domestically approved dual GLP-1/glucagon receptor agonist for weight management and glycemic control